jiangsu maxhealth pharmaceutical co., ltd.-ag真人旗舰厅网址

about us

maxhealth medical group china (herein after called maxhealth) (neeq: 836163) is a leading platform for r&d (research and development), production and commercialization of medical technology in china. based on the unsatisfied real clinical needs, maxhealth integrates the cutting-edge clinical science, continuously promotes technological progress, improves diagnosis and treatment, and helps patients through transnational innovative r&d.
we have cooperated with a number of global medical innovation institutions and top 500 pharmaceutical companies in r&d, production, market access, academy and product marketing in the chinese market, and successfully established a link between chinese and foreign medical technology r&d.
maxhealth was founded in wuxi in 2009, with. it has subsidiaries andor offices in shanghai, beijing, hong kong, london, tokyo, auckland and other places. the product portfolio will continue to expand with a focus on the areas of gastroenterology, neuro-rehabilitation and women health.the company pays special attention to digestion, women's health, nerve rehabilitation and other fields.



read more
rex: with fda and ce certification, the self balancing exoskeleton rehabilitation robot is about to enter the chinese market

in 2020, meian pharmaceutical acquired rex bionics, the world's first tier exoskeleton robot enterprise, and reorganized it into w...
read more
foundation laying ceremony of mei 'an pharmaceutical headquarter base project

read more
maxhealth medical group chin participated in the 84th cmef china international medical device (spring) exhibition

read more